Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-09-02
DOI
10.1038/s41598-022-19073-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
- (2021) Adam K. Wheatley et al. Nature Communications
- SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
- (2021) Benjamin Trinité et al. Scientific Reports
- SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
- (2021) Mikail Dogan et al. Communications Biology
- SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms
- (2021) Sarah A. Clark et al. CELL
- Clinical evaluation of the Abbott Alinity SARS-CoV-2 spike-specific quantitative IgG and IgM assays among infected, recovered, and vaccinated groups
- (2021) Madhusudhanan Narasimhan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Comparative Analysis of Antigen-Specific Anti–SARS-CoV-2 Antibody Isotypes in COVID-19 Patients
- (2021) Hidetsugu Fujigaki et al. JOURNAL OF IMMUNOLOGY
- Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants
- (2021) Saya Moriyama et al. IMMUNITY
- Performance of the Abbott SARS-CoV-2 IgG II Quantitative Antibody Assay Including the New Variants of Concern, VOC 202012/V1 (United Kingdom) and VOC 202012/V2 (South Africa), and First Steps towards Global Harmonization of COVID-19 Antibody Methods
- (2021) Emma English et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing Immunity
- (2021) Benjamin T. Bradley et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Longitudinal detection of SARS‐CoV‐2‐specific antibody responses with different serological methods
- (2021) Petra Emmerich et al. JOURNAL OF MEDICAL VIROLOGY
- SARS-CoV-2 variants, spike mutations and immune escape
- (2021) William T. Harvey et al. NATURE REVIEWS MICROBIOLOGY
- Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2
- (2020) Sairaj Satarker et al. ARCHIVES OF MEDICAL RESEARCH
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
- (2020) Shutoku Matsuyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of sex and gender on COVID-19 outcomes in Europe
- (2020) Catherine Gebhard et al. Biology of Sex Differences
- SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity
- (2020) William S Phipps et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications
- (2020) Steven Woloshin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
- (2020) Luca Piccoli et al. CELL
- Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification
- (2020) Tatsuya Fukumoto et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Kinetics of viral load and antibody response in relation to COVID-19 severity
- (2020) Yanqun Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Expansion of SARS-CoV-2–Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients
- (2020) Renata Varnaitė et al. JOURNAL OF IMMUNOLOGY
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
- (2020) Angkana T. Huang et al. Nature Communications
- COVID-19-neutralizing antibodies predict disease severity and survival
- (2020) Wilfredo F. Garcia-Beltran et al. CELL
- Humoral Responses and Serological Assays in SARS-CoV-2 Infections
- (2020) Yannick Galipeau et al. Frontiers in Immunology
- Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
- (2020) Katharina Röltgen et al. Science Immunology
- Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: Implications for the diagnosis of coronavirus infection
- (2012) Fang-Ying Liang et al. JOURNAL OF VIROLOGICAL METHODS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now